PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
1.50
1.5–2 – Reasonable coverage. Seth Klarman would verify if cyclical factors might push it below comfort levels.
1.50
1.5–2.0 – Good coverage. Seth Klarman might check if seasonal factors affect the ratio significantly.
1.48
1.0–1.5 – Enough cash to cover all current liabilities. Seth Klarman would check if the business routinely hoards cash or invests it.
-2327.49
Negative interest coverage suggests negative EBIT or an overbearing interest burden – a major red flag for Benjamin Graham.
-27.48
Negative short-term coverage ratio usually means negative OCF or an outsized near-term debt – a major Graham red flag.